Eterna Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1993
Revenue	0.07	0	0	0	19.81	23.34	21.27	22.31	24.52	26.05	Upgrade
Revenue Growth (YoY)	-	-	-	-	-15.12%	9.69%	-4.65%	-9.00%	-5.86%	9.67%	Upgrade
Cost of Revenue	0.24	0	0	0	7.48	8.07	6.76	7.71	12.57	11.15	Upgrade
Gross Profit	-0.17	0	0	0	12.32	15.27	14.52	14.6	11.95	14.9	Upgrade
Selling, General & Admin	14.59	16.84	14.72	3.3	13.18	14.46	15.59	16.46	18.06	18.37	Upgrade
Research & Development	5.92	10.39	12.71	3.95	0	0	0	0	0	0	Upgrade
Other Operating Expenses	0.79	7.13	86.3	0	0.92	0.6	0.33	0.42	0.78	1.27	Upgrade
Operating Expenses	21.3	34.36	113.73	7.25	14.09	15.06	15.92	16.88	18.84	19.64	Upgrade
Operating Income	-21.47	-34.36	-113.73	-7.25	-1.77	0.2	-1.4	-2.28	-6.9	-4.74	Upgrade
Interest Expense / Income	0.61	0.03	0	0	0.25	0.39	0.5	0.58	0.48	0.22	Upgrade
Other Expense / Income	-0.41	-9.85	8.75	0.04	-	0.14	-0.89	0.03	-0.17	-0.02	Upgrade
Pretax Income	-21.67	-24.53	-122.48	-7.29	-2.02	-0.32	-1.01	-2.89	-7.21	-4.95	Upgrade
Income Tax	-0	0.05	0.06	0	0.03	-0.06	0.07	0.04	0.01	0.08	Upgrade
Net Income	-21.67	-24.58	-122.55	-7.29	-2.05	-0.26	-1.08	-2.92	-7.23	-5.03	Upgrade
Preferred Dividends	0.02	0.02	0.02	0	0.02	0.02	0.02	0	0	0	Upgrade
Net Income Common	-21.68	-24.6	-122.56	-7.29	-2.06	-0.28	-1.09	-2.92	-7.23	-5.03	Upgrade
Shares Outstanding (Basic)	5	3	2	1	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	5	3	2	1	0	0	0	0	0	0	Upgrade
Shares Change	74.17%	40.92%	146.19%	1123.51%	6.96%	10.07%	28.32%	3.54%	4.93%	21.70%	Upgrade
EPS (Basic)	-4.08	-8.06	-56.61	-8.20	-28.80	-4.00	-18.00	-61.60	-157.20	-120.00	Upgrade
EPS (Diluted)	-4.08	-8.06	-56.61	-8.20	-28.80	-4.00	-18.00	-61.60	-157.20	-120.00	Upgrade
Free Cash Flow	-20.43	-21.02	-23.64	-8.14	1.65	-0.21	-0.9	-0.82	-5.8	-8.29	Upgrade
Free Cash Flow Per Share	-3.84	-6.89	-10.92	-9.26	22.96	-3.19	-14.79	-17.17	-126.29	-189.22	Upgrade
Gross Margin	-247.06%	-	-	-	62.22%	65.42%	68.25%	65.44%	48.73%	57.20%	Upgrade
Operating Margin	-31572.06%	-	-	-	-8.94%	0.87%	-6.59%	-10.21%	-28.12%	-18.21%	Upgrade
Profit Margin	-31888.24%	-	-	-	-10.42%	-1.18%	-5.14%	-13.10%	-29.47%	-19.31%	Upgrade
Free Cash Flow Margin	-30039.71%	-	-	-	8.33%	-0.92%	-4.24%	-3.66%	-23.67%	-31.81%	Upgrade
EBITDA	-19.93	-24.01	-122.02	-7.19	1.4	2.83	1.8	0.58	-3.63	-1.98	Upgrade
EBITDA Margin	-29314.71%	-	-	-	7.05%	12.13%	8.48%	2.59%	-14.79%	-7.59%	Upgrade
Depreciation & Amortization	1.12	0.5	0.46	0.1	3.17	2.76	2.32	2.89	3.1	2.75	Upgrade
EBIT	-21.06	-24.5	-122.48	-7.29	-1.77	0.07	-0.51	-2.31	-6.73	-4.72	Upgrade
EBIT Margin	-30966.18%	-	-	-	-8.94%	0.28%	-2.41%	-10.35%	-27.45%	-18.13%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).